CBD Life Sciences Inc. (CBDL) Launches Passion Fuel Cordyceps Complex - A Powerful Sexual Enhancement Supplement
CBD Life Sciences Inc. (CBDL) has launched Passion Fuel Cordyceps Complex, a natural sexual enhancement supplement, targeting the growing sexual wellness market projected to exceed $125 billion by 2026. The product contains 300mg of pure Cordyceps extract per serving, designed to enhance libido, stamina, and overall performance.
The supplement offers multiple benefits including improved erectile function, boosted athletic performance, enhanced blood flow, optimized hormonal balance, and increased energy levels. According to CEO Lisa Nelson, this launch represents a strategic milestone for CBDL as they expand their product line with science-backed formulations.
The company plans to distribute Passion Fuel through major online marketplaces, wellness retailers, and direct-to-consumer platforms, while exploring global strategic partnerships. This launch aligns with CBDL's expansion strategy in the dietary supplement market, which exceeded $177 billion in 2023.
CBD Life Sciences Inc. (CBDL) ha lanciato Passion Fuel Cordyceps Complex, un integratore naturale per il miglioramento sessuale, mirato al crescente mercato del benessere sessuale, previsto superare i 125 miliardi di dollari entro il 2026. Il prodotto contiene 300 mg di estratto puro di Cordyceps per porzione, progettato per migliorare la libido, la resistenza e le prestazioni complessive.
L'integratore offre molteplici benefici, tra cui una funzione erettile migliorata, prestazioni atletiche potenziate, flusso sanguigno ottimizzato, equilibrio ormonale migliorato e livelli di energia aumentati. Secondo il CEO Lisa Nelson, questo lancio rappresenta una pietra miliare strategica per CBDL mentre espandono la loro linea di prodotti con formulazioni supportate dalla scienza.
L'azienda prevede di distribuire Passion Fuel attraverso importanti marketplace online, rivenditori di benessere e piattaforme di vendita diretta al consumatore, mentre esplora partnership strategiche globali. Questo lancio si allinea con la strategia di espansione di CBDL nel mercato degli integratori alimentari, che ha superato i 177 miliardi di dollari nel 2023.
CBD Life Sciences Inc. (CBDL) ha lanzado Passion Fuel Cordyceps Complex, un suplemento natural para el aumento sexual, dirigido al creciente mercado del bienestar sexual, que se proyecta que superará los 125 mil millones de dólares para 2026. El producto contiene 300 mg de extracto puro de Cordyceps por porción, diseñado para mejorar la libido, la resistencia y el rendimiento general.
El suplemento ofrece múltiples beneficios, incluyendo una función eréctil mejorada, un rendimiento atlético potenciado, un flujo sanguíneo mejorado, un equilibrio hormonal optimizado y niveles de energía aumentados. Según la CEO Lisa Nelson, este lanzamiento representa un hito estratégico para CBDL mientras amplían su línea de productos con formulaciones respaldadas por la ciencia.
La empresa planea distribuir Passion Fuel a través de importantes mercados en línea, minoristas de bienestar y plataformas de venta directa al consumidor, mientras explora asociaciones estratégicas globales. Este lanzamiento se alinea con la estrategia de expansión de CBDL en el mercado de suplementos dietéticos, que superó los 177 mil millones de dólares en 2023.
CBD Life Sciences Inc. (CBDL)는 Passion Fuel Cordyceps Complex를 출시했습니다. 이는 자연 성적 강화 보충제로, 2026년까지 1,250억 달러를 초과할 것으로 예상되는 성장하는 성 건강 시장을 목표로 하고 있습니다. 이 제품은 300mg의 순수한 Cordyceps 추출물을 1회 제공량에 포함하고 있으며, 성욕, 지구력 및 전반적인 성능을 향상시키기 위해 설계되었습니다.
이 보충제는 개선된 발기 기능, 향상된 운동 성능, 최적화된 혈류, 호르몬 균형 향상 및 에너지 수준 증가 등 여러 가지 이점을 제공합니다. CEO 리사 넬슨에 따르면, 이번 출시는 CBDL이 과학 기반의 포뮬레이션으로 제품 라인을 확장하는 전략적 이정표를 나타냅니다.
회사는 주요 온라인 마켓플레이스, 웰빙 소매업체 및 소비자 직접 판매 플랫폼을 통해 Passion Fuel을 유통할 계획이며, 글로벌 전략적 파트너십을 탐색하고 있습니다. 이번 출시는 2023년 1,770억 달러를 초과한 건강 보조 식품 시장에서 CBDL의 확장 전략과 일치합니다.
CBD Life Sciences Inc. (CBDL) a lancé Passion Fuel Cordyceps Complex, un complément naturel d'amélioration sexuelle, visant le marché croissant du bien-être sexuel, qui devrait dépasser 125 milliards de dollars d'ici 2026. Le produit contient 300 mg d'extrait pur de Cordyceps par portion, conçu pour améliorer la libido, l'endurance et les performances globales.
Le complément offre de multiples avantages, notamment une fonction érectile améliorée, des performances sportives renforcées, un flux sanguin amélioré, un équilibre hormonal optimisé et des niveaux d'énergie accrus. Selon la PDG Lisa Nelson, ce lancement représente une étape stratégique pour CBDL alors qu'ils élargissent leur gamme de produits avec des formulations basées sur la science.
L'entreprise prévoit de distribuer Passion Fuel via des marketplaces en ligne majeurs, des détaillants de bien-être et des plateformes de vente directe au consommateur, tout en explorant des partenariats stratégiques mondiaux. Ce lancement s'inscrit dans la stratégie d'expansion de CBDL sur le marché des compléments alimentaires, qui a dépassé 177 milliards de dollars en 2023.
CBD Life Sciences Inc. (CBDL) hat Passion Fuel Cordyceps Complex eingeführt, ein natürliches Nahrungsergänzungsmittel zur sexuellen Verbesserung, das auf den wachsenden Markt für sexuelles Wohlbefinden abzielt, der bis 2026 voraussichtlich über 125 Milliarden Dollar übersteigen wird. Das Produkt enthält 300 mg reinen Cordyceps-Extrakt pro Portion, das entwickelt wurde, um Libido, Ausdauer und Gesamtleistung zu steigern.
Das Nahrungsergänzungsmittel bietet mehrere Vorteile, einschließlich verbesserter erektiler Funktion, gesteigerter sportlicher Leistung, verbessertem Blutfluss, optimiertem hormonellem Gleichgewicht und erhöhten Energielevels. Laut CEO Lisa Nelson stellt dieser Launch einen strategischen Meilenstein für CBDL dar, während sie ihre Produktlinie mit wissenschaftlich fundierten Formulierungen erweitern.
Das Unternehmen plant, Passion Fuel über große Online-Marktplätze, Wellness-Einzelhändler und Direktvertriebsplattformen zu vertreiben und gleichzeitig globale strategische Partnerschaften zu erkunden. Dieser Launch steht im Einklang mit CBDLs Expansionsstrategie im Markt für Nahrungsergänzungsmittel, der 2023 über 177 Milliarden Dollar überstieg.
- Entry into fast-growing sexual wellness market projected at $125B by 2026
- Product targets both sexual wellness and athletic performance markets
- Multiple distribution channels planned including online marketplaces and wellness retailers
- Strategic positioning in dietary supplement market valued at $177B in 2023
- No revenue projections or sales targets provided
- High competition in crowded supplement market
- No mention of production costs or profit margins
The global sexual wellness market is projected to surpass
SCOTTSDALE, AZ / ACCESS Newswire / March 27, 2025 / CBD Life Sciences Inc. (OTC PINK:CBDL) is making waves in the booming health and wellness industry with the launch of its latest breakthrough product: Passion Fuel Cordyceps Complex. This cutting-edge supplement is designed to supercharge libido, enhance stamina, improve blood flow, and optimize overall performance, providing an all-natural solution for individuals looking to elevate their intimate and athletic experiences.
Each serving of Passion Fuel Cordyceps Complex delivers a potent 300mg dose of pure Cordyceps extract (150mg per pill, 2 pills per serving)-a revered medicinal mushroom known for its powerful adaptogenic properties. Backed by scientific research, Cordyceps has been shown to increase oxygen uptake, improve circulation, boost testosterone levels, and enhance endurance, making it a game-changer for those seeking peak physical and sexual performance.
"This launch is a major milestone for CBDL as we continue to expand our product line with high-demand, science-backed formulations," said Lisa Nelson, President & CEO of CBD Life Sciences Inc. "With the sexual wellness market projected to skyrocket past
Unleashing the Power of Cordyceps for Peak Performance Passion Fuel Cordyceps Complex offers a wide range of benefits, including:
Enhanced libido & improved erectile function - Naturally increases testosterone and supports sexual health.
Boosted stamina & athletic performance - Increases ATP production, delivering sustained energy and endurance.
Improved blood flow & circulation - Supports heart health and oxygenation for peak physical function.
Optimized hormonal balance - Helps regulate cortisol and stress levels, fostering overall well-being.
Increased energy & vitality - Fights fatigue and enhances metabolic efficiency for all-day performance.
A Strategic Move for Future Growth The release of Passion Fuel Cordyceps Complex aligns with CBDL's aggressive expansion strategy, tapping into an industry that continues to experience unprecedented demand. With the dietary supplement market exceeding
As the company accelerates its growth trajectory, Passion Fuel Cordyceps Complex is set to be distributed across major online marketplaces, wellness retailers, and direct-to-consumer platforms. CBDL is also actively exploring strategic partnerships to bring this powerhouse supplement to new audiences globally.


About CBD Life Sciences Inc. CBD Life Sciences Inc. (OTC: CBDL) is a leader in the rapidly expanding health and wellness industry, specializing in cutting-edge CBD-based and plant-derived formulations. With a commitment to innovation and quality, CBDL continues to develop science-backed products designed to optimize health, performance, and longevity.
Follow our social media for the latest updates!
X: https://www.x.com/CBDL_StockOTC
Instagram: https://www.instagram.com/cbd.vault
IR Contact: cbdvaultaz@gmail.com
Stay Connected & Be the First to Try Our New Functional Mushroom Products!
Mushroom Madness Instagram: https://www.instagram.com/mushroom.madnessaz
Mushroom Madness Website: https://www.mushroommadness.shop
Forward-Looking Statements
Except for the historical information contained herein, the matters discussed in this press release are forward-looking statements. Actual results may differ materially from those described in forward-looking statements and are subject to risks and uncertainties. See CBD Life Sciences, Inc's, Inc.'s filings with OTC Markets, which may identify specific factors that may cause actual results or events to differ materially from those described in the forward-looking statements.
Safe Harbor Statement
This release includes forward-looking statements, which are based on certain assumptions and reflects management's current expectations. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations. Some of these factors include: general global economic conditions; general industry and market conditions, sector changes and growth rates; uncertainty as to whether our strategies and business plans will yield the expected benefits; increasing competition; availability and cost of capital; the ability to identify and develop and achieve commercial success; the level of expenditures necessary to maintain and improve the quality of services; changes in the economy; changes in laws and regulations, including codes and standards, intellectual property rights, and tax matters; or other matters not anticipated; our ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking statements.
Contact Information
Lisa Nelson
CEO
cbdvaultaz@gmail.com
4802091720
SOURCE: CBD Life Sciences, Inc.
View the original press release on ACCESS Newswire